US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
Zacks.com on MSN22h
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?UnitedHealth Group Incorporated UNH is currently viewed as expensive, with the stock trading at a 19.09X forward 12-month ...
This was the stock's second consecutive day of losses.
We recently compiled a list of the 12 Best Forever Stocks To Buy Now. In this article, we are going to take a look at where ...
UnitedHealth Group Inc. struck a tentative deal to settle a class action challenging the Wells Fargo & Co. target date funds ...
UnitedHealth Group Inc. closed $30.87 below its 52-week high ($607.94), which the company achieved on September 4th.
UnitedHealth Group had been stumbling through the first half of 2024 with bad news after bad news. Read why I upgrade UNH ...
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
The majority of cuts will take place in December, according to a notice filed with the state of New Jersey this month.
UnitedHealth Group’s (NYSE:UNH) acquisition of Amedisys (Nasdaq:AMED) is still pending. That could be due to a variety of factors, but one is clear: ...
Compared to its industry, the company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback